Regenokine is a patented procedure that involves drawing blood from a patient and then separating and treating it with heat to concentrate its healing properties. The incubation process takes up to 24 hours, and it stimulates the growth of immune-regulating substances from the body, like tumor necrosis factor and interleukin-1. Once the blood is ready, it's injected directly into the joint or other source of pain. Since the procedure is noninvasive, it carries little risk of side effects like infections and does not require months of physical rehabilitation. While no one knows exactly how long the relief will last, Wehling says he usually doesn't see patients for years afterward, and in some cases, such as when he treats slipped discs, he is confident the treatment can offer a permanent fix, especially when patients follow injections with Wehling's nutrition and training program. "This is a new, proven way of treating chronic pain," says Wehling. "We see a positive result in 80 to 90 percent of patients."